Ellianne Nasser, DPM
Podiatrist · Scranton, PANPI 1649584764
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.7%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 10 manufacturers reported payments, led by Paragon 28, Inc. at 50.8% of the total. Reporting peaked in 2023 at $18,652 and has fallen 55.0% since, to $8,386 in 2025. Among podiatrist clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 60 payments — averaging $582.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$18K
- Synthes GmbH$11K
- Arthrex$3K
- Novus Surgical Solutions LLC$1K
- Stryker$1K
- Integra Lifesciences Corporation$167
- plus $343 from 4 others
What the payments were for
- Consulting fees$15,97146%
- Speaking & faculty fees$7,00020%
- Travel & lodging$7,99323%
- Food & beverage$2,8088%
- Education$1,2003%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 13 | $17,773 |
| Synthes GmbH | 18 | $11,212 |
| Arthrex | 1 | $3,000 |
| Novus Surgical Solutions LLC | 2 | $1,344 |
| Stryker | 12 | $1,133 |
| Integra Lifesciences Corporation | 7 | $167 |
| Kerecis Limited | 3 | $142 |
| Treace Medical Concepts, Inc. | 2 | $97 |
| Novus Surgical Consultants | 1 | $63 |
| Reddress USA, Inc. | 1 | $40 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Portfolio$15,962
- PARATROOPER$1,387
- HOFFMANN$349
- Product Portfolio$349
- INFINITY$260
- Actishield$166
- VARIAX$123
- ALLOWRAP$117
- AUGMENT INJECTABLE$117
- AXSOS$117
How this compares
$34,971 in reported general payments places this provider in the 95th percentile of 445 podiatrist providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $57 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Scranton
- Mark HofbauerBelle Vernon$1.1M
- Daniel PerezPhiladelphia$434K
- Christopher BarrettChester$229K
- Alan CatanzaritiPittsburgh$80K
- John StarinskiPen Argyl$74K
- Kwasi KwaaduPhiladelphia$65K
- Luke CicchinelliPhiladelphia$62K
- James McGuirePhiladelphia$60K
- John SchelandClarks Summit$54K
- John LapelusaYork$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.